ProfileGDS4132 / 203191_at
TitlePPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
OrganismHomo sapiens


pretreatment pioglitazone GSM201542 GSM201543 GSM201544 GSM201545 GSM201829 GSM201830 GSM201831 GSM201832 GSM201833 GSM201834 GSM201835 GSM201836 GSM201837 GSM201838 GSM201839 GSM201840 GSM201841 GSM201842 GSM201843 GSM201844 76% 74% 50% 44% 73% 75% 62% 79% 37% 51% 28% 30% 26% 25% 26% 32% 30% 29% 29% 33% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM201542Muscle PCOS pioglitazone 101242.66776
GSM201543Muscle PCOS pioglitazone 121221.8674
GSM201544Muscle PCOS pioglitazone 161136.72350
GSM201545Muscle PCOS pioglitazone 201122.29644
GSM201829Muscle PCOS pioglitazone 231239.78773
GSM201830Muscle PCOS pioglitazon 251243.47675
GSM201831Muscle PCOS pioglitazone 271182.01562
GSM201832Muscle PCOS pioglitazone 31251.29279
GSM201833Muscle PCOS pioglitazone 4189.889537
GSM201834Muscle PCOS pioglitazone 81135.30951
GSM201835Muscle PCOS after pioglitazone 10255.459928
GSM201836Muscle PCOS after pioglitazone 12262.94930
GSM201837Muscle PCOS after pioglitazone 16250.204426
GSM201838Muscle PCOS after pioglitazone 20252.064225
GSM201839Muscle PCOS after pioglitazone 23255.09926
GSM201840Muscle PCOS after pioglitazone 25274.73332
GSM201841Muscle PCOS after pioglitazone 27259.473130
GSM201842Muscle PCOS after pioglitazone 3255.355429
GSM201843Muscle PCOS after pioglitazone 4268.54729
GSM201844Muscle PCOS after pioglitazone 8276.923733